Helus Pharma Inc.
HELP | NASDAQ
$10.60
-$0.11 (-1.03%)
At close: Oct 30, 2026, 4:00 PM ET
$10.76
+$0.16 (+1.48%)
Pre-market:
Nov 2, 2026, 5:54 AM ET
TTM Period Ending | Q1 2027 Jun 30, 2026 | Q4 2026 Mar 31, 2026 | Q3 2026 Dec 31, 2025 | Q2 2026 Sep 30, 2025 | Q1 2026 Jun 30, 2025 | Q4 2025 Mar 31, 2025 | Q3 2025 Dec 31, 2024 | Q2 2025 Sep 30, 2024 | Q1 2025 Jun 30, 2024 | Q4 2024 Mar 31, 2024 | Q3 2024 Dec 31, 2023 | Q2 2024 Sep 30, 2023 | Q1 2024 Jun 30, 2023 | Q4 2023 Mar 31, 2023 | Q3 2023 Dec 31, 2022 | Q2 2023 Sep 30, 2022 | Q1 2023 Jun 30, 2022 | Q4 2022 Mar 31, 2022 | Q3 2022 Dec 31, 2021 | Q2 2022 Sep 30, 2021 | Q1 2022 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 30.21K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 511K | 511K | 511K |
Gross Profit | -30.21K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -511K | -511K | -511K |
Operating Income | -177.17M | -153.95M | -139.37M | -130.39M | -148.04M | -138.27M | -130.19M | -125.02M | -80.98M | -78.84M | -67.34M | -52.41M | -50.83M | -51.52M | -54.15M | -58.52M | -63.29M | -63.84M | -60.38M | -55.3M | -38.24M |
Interest Income | 5.81M | 5.27M | 5.13M | 5.3M | 6.88M | 7.74M | 6.64M | 5.11M | 2.1M | 619K | 425K | 441K | 563K | 603K | 538K | 444K | 321K | 241K | 204.12K | 155.12K | 104.12K |
Pretax Income | -183.27M | -161.27M | -144.85M | -113.06M | -122.93M | -109.15M | -99.92M | -119.41M | -74.4M | -78.08M | -70.45M | -50.87M | -48.95M | -47.49M | -51.87M | -58.34M | -65.97M | -67.63M | -63.31M | -57.52M | -40.06M |
Net Income | -183.27M | -161.27M | -144.85M | -113.06M | -122.93M | -109.15M | -99.92M | -119.41M | -74.4M | -78.08M | -70.45M | -50.87M | -48.95M | -47.49M | -51.87M | -58.34M | -65.97M | -67.63M | -63.31M | -57.52M | -42.57M |
Selling & General & Admin | 68.15M | 59.95M | 55.28M | 50.81M | 85.69M | 85.04M | 84.09M | 90.59M | 48.63M | 45.78M | 38.04M | 24.43M | 24.4M | 25.37M | 30.09M | 35.21M | 40.68M | 44.03M | 44.56M | 44.31M | 31.99M |
Research & Development | 108.99M | 94.01M | 84.09M | 79.57M | 62.35M | 53.23M | 46.11M | 34.43M | 32.34M | 33.05M | 29.3M | 27.99M | 26.43M | 26.15M | 24.06M | 23.31M | 22.62M | 19.81M | 15.22M | 10.39M | 6.09M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 90.57K | 90.57K | -344.43K |
Operating Expenses | 177.14M | 153.95M | 139.37M | 130.39M | 148.04M | 138.27M | 130.19M | 125.02M | 80.98M | 78.84M | 67.34M | 52.41M | 50.83M | 51.52M | 54.15M | 58.52M | 63.29M | 63.84M | 59.86M | 54.79M | 37.73M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 214 | 214 | 214 |
Selling & Marketing Expenses | 6.2M | 6.96M | 5.42M | 4.98M | 5.41M | 4.69M | 3.42M | 2.82M | 1.91M | 1.9M | 62K | 105K | 180K | 881K | 1.18M | 1.51M | 1.83M | 1.47M | 4.35M | 4.16M | 3.76M |
Cost & Expenses | 177.17M | 153.95M | 139.37M | 130.39M | 148.04M | 138.27M | 130.19M | 125.02M | 80.98M | 78.84M | 67.34M | 52.41M | 50.83M | 51.52M | 54.15M | 58.52M | 63.29M | 63.84M | 60.38M | 55.3M | 38.24M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.51M |
Shares Outstanding (Basic) | 52.32M | 50.29M | 24.21M | 24.21M | 22.4M | 20.9M | 20M | 20M | 19.59M | 20M | 8.78M | 6.17M | 5.43M | 5.16M | 4.97M | 4.76M | 4.63M | 4.58M | 4.52M | 4.36M | 4.15M |
Shares Outstanding (Diluted) | 52.32M | 50.29M | 24.21M | 24.21M | 22.4M | 20.9M | 20M | 20M | 19.59M | 20M | 8.78M | 6.17M | 5.43M | 5.16M | 4.97M | 4.76M | 4.63M | 4.58M | 4.52M | 4.36M | 4.15M |
EPS (Basic) | -5.51 | -5.72 | -6.26 | -5.04 | -5.94 | -5.39 | -5 | -7.91 | -7 | -9.13 | -10.72 | -9.43 | -9.60 | -9.74 | -11.04 | -12.69 | -14.63 | -15.36 | -14.88 | -15.01 | -12.43 |
EPS (Diluted) | -5.51 | -5.72 | -6.26 | -5.04 | -5.94 | -5.39 | -5 | -7.91 | -7 | -9.13 | -10.72 | -9.43 | -9.60 | -9.74 | -11.04 | -12.69 | -14.63 | -15.36 | -14.88 | -15.01 | -12.43 |
EBITDA | -177.05M | -153.83M | -139.21M | -130.11M | -147.67M | -137.83M | -129.67M | -124.5M | -80.52M | -78.41M | -66.99M | -52.13M | -50.56M | -51.27M | -53.93M | -58.32M | -63.11M | -63.67M | -60.22M | -55.21M | -38.19M |
EBIT | -177.17M | -153.95M | -139.37M | -130.39M | -148.04M | -138.27M | -130.19M | -125.02M | -80.98M | -78.84M | -67.34M | -52.41M | -50.83M | -51.52M | -54.15M | -58.52M | -63.29M | -63.84M | -60.38M | -55.34M | -38.28M |
Depreciation & Amortization | 123.64K | 127.42K | 158.42K | 271.62K | 373.67K | 440.68K | 520.68K | 527.5K | 456K | 424K | 350K | 279K | 267K | 251K | 227K | 200K | 183K | 168K | 160.04K | 129.04K | 87.04K |
Add to Watchlist
Select watchlists to add or remove HELP